Materialise NV filed a Form 6-K with the SEC for the month of October 2026, reporting third quarter 2026 financial results including total revenue of 67,670 kEUR and net profit of 1,383 kEUR.

Key Highlights

  • Total revenue rose 2.1% to 67,670 kEUR in Q3 2026 from 66,259 kEUR in Q3 2025, according to the filing.
  • Materialise Medical segment revenue grew 9.7% to 36,542 kEUR, while Manufacturing revenue declined to 21,266 kEUR from 22,677 kEUR.
  • Gross profit increased 3.7% to 39,035 kEUR, with gross margin improving to 57.7% from 56.8% in the prior-year period.
  • Operating profit fell to 1,343 kEUR from 2,522 kEUR in Q3 2025, partly due to non-recurring inventory impairment charges of 184 kEUR related to the transfer of Eyewear assets.
  • Net cash position increased by 11,668 kEUR to 82,473 kEUR at September 30, 2026, compared to 70,805 kEUR at December 31, 2025.
  • Share buy-back program had resulted in repurchase of 1,426,784 own shares for a total of 7,482 kEUR (8,698 kUSD) as of quarter-end.
  • Adjusted EBITDA was 8,046 kEUR for Q3 2026, compared to 8,428 kEUR for Q3 2025.

Materialise Q3 2026 Segment Performance and Profitability Details

According to the Form 6-K filed by Materialise NV (NASDAQ:MTLS) for the month of October 2026, total revenue for the third quarter of 2026 reached 67,670 kEUR, a 2.1% increase from 66,259 kEUR in the same period of 2025. The company's three business segments showed mixed performance: Materialise Medical grew 9.7% to 36,542 kEUR, Materialise Software declined to 9,864 kEUR from 10,286 kEUR, and Materialise Manufacturing fell to 21,266 kEUR from 22,677 kEUR.

The filing reported that gross profit rose 3.7% to 39,035 kEUR, with gross profit as a percentage of revenue improving to 57.7% from 56.8%. However, operating profit declined to 1,343 kEUR from 2,522 kEUR in Q3 2025. The filing attributed this in part to combined R&D, S&M, and G&A expenses rising 7.8% in aggregate to 38,830 kEUR, "mainly driven by 11.9% higher R&D spend." The filing also noted non-recurring charges of 184 kEUR from inventory impairment related to the transfer of Eyewear assets. Net profit for the quarter was 1,383 kEUR, down from 1,848 kEUR in Q3 2025.

On the balance sheet, the filing disclosed that cash and cash equivalents increased to 153,529 kEUR at September 30, 2026 from 133,918 kEUR at December 31, 2025, while gross debt rose to 71,056 kEUR from 63,113 kEUR over the same period, resulting in a net cash position of 82,473 kEUR. Net shareholders' equity increased to 255,809 kEUR from 255,482 kEUR at December 31, 2025. Cash flow from operating activities for the quarter was 9,666 kEUR, and free cash flow after operating and investing activities was 11,419 kEUR, according to the filing.

What Was Disclosed

Materialise NV disclosed its unaudited third quarter and nine-month 2026 financial results via a Form 6-K, covering revenue, profitability, segment performance, cash position, and progress under its share buy-back program as of September 30, 2026.